researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still has several fundamental strong points, including an extensive pipeline of ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

including an extensive pipeline of therapeutics in clinical trials that could be the booster shot the stock needs to generate a rebound. Let's discuss the pros and cons of buying Moderna stock.

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

A booster shot is an additional dose of a COVID-19 vaccine ... country in the world due to agreements with Pfizer/BioNTech, Moderna, AstraZeneca, Medicago, Sanofi-GlaxoSmithKline, Novavax and ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

The FDA was already scrutinizing Moderna's RSV pediatric vaccine trial, paused without explanation this ... The U.S. feathered its own bed by approving an updated Moderna booster last summer. CEO ...